- Study Measures HIV Anti-Retroviral Regimens' Safety and Efficacy
- FDA: Glaxo warns of heart risk from HIV drug
- Rethinking AIDS Meds
- HIV Co-Pay Programs
- Anti-Retroviral Therapy Lowers Healthcare Costs
- NIH Updates Guidlines on Antiretroviral Agents in HIV Infected Adults and Adolescents
- Researchers Say Antiretroviral (ART) Drugs May Prevent HIV Infection
- HIV Drug Combination Carries Heart Rsk
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
- Increased HAART Coverage Associated With 50 Percent Drop in New Infections
- Focus on Primary Health Care is Needed to Fight AIDS
- Nurse Attitudes, Clinic Experience, Key to Improving Care and Retention in ARV Programmes
- HIV’s Deadliest Strain







